Summary
For too long, Eastern and Western cultures have approached the epidemiology, diagnosis, therapy, and prevention of pulmonary embolism in cultural isolation. Although the discovery of the factor V Leiden genetic mutation has revolutionized the epidemiology of venous thromboembolism in Caucasian populations of European ancestry, this finding has not advanced the epidemiological approach to pulmonary embolism in Japan, because this genetic mutation is so rare in Asians. However, advances in reliable noninvasive diagnostic techniques have been welcomed in the East and the West, particularly the D-dimer ELISA, echocardiography, spiral chest CT scanning, and magnetic resonance imaging. The use of subcutaneously administered low molecular weight heparins has made home treatment possible for pulmonary embolism patients at low risk. Perhaps the most exciting advance in therapy is implementation of routine risk stratification, especially by establishing the status of the right ventricle. Right ventricular hypokinesis on echocardiography is becoming increasingly recognized as a poor prognostic sign. By understanding that pulmonary embolism encompasses a wide clinical spectrum, those patients at high risk of an adverse outcome can be selected for thrombolysis or catheter-based or surgical embolectomy in addition to anticoagulation. Finally, prevention of venous thromboembolism is crucially important. While effective pharmacologic strategies can be implemented, especially with low molecular weight heparins, mechanical measures such as insertion of an inferior vena caval filter are also effective.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Svensson PJ, Dahlbäck B (1994) Resistance to activated protein C as a basis for venous thrombosis. New Engl J Med 330: 517 - 522
Bertina RM, Koeleman BPC, Koster T et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369: 64 - 67
Ridker PM, Hennekens CH, Lindpaintner K (1995) Mutation in the gene coding for coagulation factor V and risks of future myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 332: 912 - 917
Ridker PM, Miletich JP, Hennekens CH, Buring JE (1997) Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 277: 1305-1307
Bounameaux H, de Moerloose P, Perrier A, Miron MJ (1997) D-dimer testing in suspected venous thromboembolism: an update. Q J Med 90: 437 - 442
Jardin F, Dubourg O, Bourdarias JP (1997) Echocardiographic pattern of acute cor pulmonale. Chest 111: 209 - 217
Remy-Jardin M, Remy J, Deschildre F et al. (1996) Diagnosis of pulmonary embolism with spiral CT: comparison with pulmonary angiography and scintigraphy. Radiology 200: 699 - 706
Goodman LR, Lipchik RJ (1996) Diagnosis of acute pulmonary embolism: time for a new approach. Radiology 199: 25 - 27
Lensing AWA, Prandoni P, Brandjes D et al. (1989) Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N Engl J Med 320: 342 - 345
Weitz JI (1997) Low-molecular-weight heparins. N Engl J Med 337: 688 - 698
Koopman MMW, Prandoni P, Piovella F et al. (1996) Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared Overview of Pulmonary Embolism 15 with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 334: 682 - 687
Levine M, Gent M, Hirsh J et al. (1996) A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 334: 677 - 681
The Columbus Investigators (1997) Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 337: 657 - 662
Simonneau G, Sors H, Charbonnier B et al. (1997) A comparison of low-molecularweight-heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 337: 663 - 669
Cannon CP, Goldhaber SZ (1995) The importance of rapidly treating patients with acute myocardial infarction. Chest 107: 598 - 600
Goldhaber SZ, Visani L, De Rosa M (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry Lancet. (in press)
Price DT, Ridker PM (1997) Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Ann Intern Med 127: 895 - 903
Simioni P, Prandoni P, Lensing AWA et al. (1997) The risk of recurrent venous thromboembolism in patients with an Arg500 ---> Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med 336: 399 - 403
Ridker PM, Miletich JP, Stampfer MJ et al. (1995) Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation 92: 2800 - 2802
Hirsch DR, Ingenito EP, Goldhaber SZ (1995) Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 274: 335 - 337
Goldhaber SZ (1998) Venous thromboembolism in the Intensive Care Unit: the last frontier for prophylaxis. Chest 113: 5 - 7
Elliott CG (1992) Pulmonary physiology during pulmonary embolism. Chest 101: 1635 - 171S
Anderson FA Jr, Wheeler HB, Goldberg RJ et al. (1991) A population-based perspective of the hospital incidence and case-fatality rates of venous thrombosis and pulmonary embolism: The Worcester DVT Study. Arch Intern Med 151: 933938
Ribeiro A, Lindmarker P, Juhlin-Dannfelt A, Johnsson H, Jorfeldt L (1997) Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as predictor of mortality. Am Heart J 134: 479 - 487
Kasper W, Konstantinides S, Geibel A et al. (1997) Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart 77: 346 - 349
Kasper W, Konstantinides S, Geibel A et al. (1997) Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 30: 1165 - 1171
Goldhaber SZ, Grodstein F, Stampfer MJ et al. (1997) A prospective study of risk factors for pulmonary embolism in women. JAMA 277: 642 - 645
Koonin LM, Atrash HK, Lawson HW, Smith JC (1991) Maternal Mortality Surveillance, United States, 1979-1986. CDC Surveillance Summaries. MMWR 40: 1-8
World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1995) Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet 346: 1575 - 1582
World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1995) Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 346: 15821588
Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C (1995) Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 346: 1589 - 1593
Daly E, Vessey MP, Hawkins MM (1996) Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 348: 977 - 980
Jick H. Derby LE, Myers MW, Vasilakis C, Newton KM (1996) Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet 348: 981 - 983
Grodstein F, Stampfer MJ, Goldhaber SZ (1996) Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 348: 983 - 987
Bergqvist D, Lindblad B (1985) A 30-year survey of pulmonary embolism verified at autopsy: an analysis of 1274 surgical patients. Br J Surg 72: 105 - 108
Huber O, Bounameaux H, Borst F, Rohner A (1992) Postoperative pulmonary embolism after hospital discharge. An underestimated risk. Arch Surg 127: 310-313
Prandoni P, Lensing AWA, Büller HR et al. (1992) Deep vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 327: 1128 - 1133
Piccioli A, Prandoni P, Ewenstein BM, Goldhaber SZ (1996) Cancer and venous thromboembolism. Am Heart J 132: 850 - 855
Ridker PM, Glynn RJ, Miletich JP et al. (1997) Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ann Intern Med 126: 528 - 531
Simioni P, Prandoni P, Burlina A et al. (1996) Hyperhomocysteinemia and deep-vein thrombosis. A case control study. Thromb Haemost 76: 883-886
den Heijer M, Koster T, Blom HJ (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334: 759 - 762
Ridker PM, Hennekens CH, Selhub J et al. (1997) Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation 95: 1777 - 1782
Hughes GRV (1993) The antiphospholipid syndrome: ten years on. Lancet 342: 341344
Heijboer H, Brandjes DPM, Büller HR, Sturk A, ten Cate JW (1990) Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 323: 1512 - 1516
Ferrari E, Imbert A, Chevalier T et al. (1997) The ECG in pulmonary embolism. Predictive value of negative T waves in precordial leads-80 case reports. Chest 111: 537 - 543
Stein PD, Goldhaber SZ, Henry JW, Miller AC (1996) Arterial blood gas analysis in the assessment of suspected acute pulmonary embolism. Chest 109: 78 - 81
Stein, PD, Goldhaber SZ, Henry JW (1995) Alveolar-arterial oxygen gradient in the assessment of acute pulmonary embolism. Chest 107: 139 - 143
Bounameaux H, de Moerloose P, Perrier A, Miron MJ (1997) D-dimer testing in suspected venous thromboembolism: an update. Q J Med 90: 437 - 442
Hull RD, Hirsh J, Carter CJ et al. (1983) Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med 98:891-899 Overview of Pulmonary Embolism 17
PIOPED Investigators (1990) Value of the ventilation perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 263: 2753 - 2759
Gottschalk A, Sostman HD, Coleman RE et al. (1993) Ventilation-perfusion scintigraphy in the PIOPED study. Part II. Evaluation of the scintigraphic criteria and interpretations. J Nucl Med 34: 1119-1126
Stein PD, Terrin ML, Gottschalk A, Alavi A, Henry JW (1992) Value of ventilation/perfusion scans versus perfusion scans alone in acute pulmonary embolism. Am J Cardiol 69: 1239 - 1242
Bone RC (1993) The low-probability lung scan. A potentially lethal reading. Arch Intern Med 153: 2621 - 2622
Hull RD, Raskob GE, Pineo GF, Brant RF (1995) The low-probability lung scan. A need for change in nomenclature. Arch Intern Med 155: 1845-1851
Remy-Jardin M, Remy J, Deschildre F et al. (1996) Diagnosis of pulmonary embolism with spiral CT: comparison with pulmonary angiography and scintigraphy. Radiology 200: 699 - 706
Meaney JFM, Weg JG, Chenevert TL et al. (1997) Diagnosis of pulmonary embolism with magnetic resonance angiography. N Engl J Med 336: 1422 - 1427
Jardin F, Dubourg O, Bourdarias JP (1997) Echocardiographic pattern of acute cor pulmonale. Chest 111: 209 - 217
McConnell MV, Solomon SD, Rayan ME et al. (1996) Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism ( The "hinge point" sign ). Am J Cardiol 78: 769-473
Stein PD, Athanasoulis C, Alavi A et al. (1992) Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation 85: 462 - 468
Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S (1993) The weight-based heparin dosing nomogram compared with a "standard care" nomogram: a randomized controlled trial. Ann Intern Med 119: 874 - 881
Hull RD, Raskob GE, Brant RF, Pineo GF, Valentine KA (1997) Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Arch Intern Med 157: 2562 - 2568
Toglia M R, Weg JG (1996) Venous thromboembolism during pregnancy. N Engl J Med 335: 108 - 114
Callander N, Rapaport SI (1993) Trousseau's syndrome. West J Med 158: 364 - 371
The COLUMBUS Investigators (1997) Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 337: 657 - 662
Simonneau G, Sors H, Charbonnier B et al. (1997) A comparison of low-molecularweight-heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 337: 663 - 669
Pacouret G, Alison D, Pottier J-M, Bertrand P, Charbonnier B (1997) Free-floating thrombus and embolis risk in patients with angiographically confirmed proximal deep venous thrombosis. A prospective study. Arch Intern Med 157: 305-308
Decousus H, Leizorovicz A, Parent F et al. (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 338: 409 - 415
Harrison L, Johnston M, Massicotte MP, Crowther M, Moffat K, Hirsh J. Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med 126: 133 - 136
Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE (1998) Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA 279: 657 - 662
Schulman S, Rhedin A-S, Lindmarker P et al. (1995) A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboemholism. N Engl J Med 332: 1661 - 1665
Schulman S, Granqvist S, Holmström et al. (1997) The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 336: 393 - 398
Goldhaber SZ, Haire WD, Feldstein ML et al. (1993) Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right ventricular function and pulmonary perfusion. Lancet 341: 507 - 511
Konstantinides S, Geibel A, Olschewski M et al. (1997) Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism. Results of a multicenter registry. Circulation 96: 882-888
Mikkola KM, Patel SR, Parker JA, Grodstein F, Goldhaber SZ (1997) Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis. Am Heart J 134: 69 - 72
Greenfield LJ, Proctor MC, Williams DM, Wakefield TW (1993) Long-term experience with transvenous catheter pulmonary embolectomy. J Vasc Surg 18: 450 - 458
Gulba DC, Schmid C, Borst H-G et al. (1994) Medical compared with surgical treatment for massive pulmonary embolism. Lancet 343: 576 - 577
Collins R, Scrimgeour A, Yusuf S, Peto R (1988) Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 318: 1162-1173
Weitz JI (1997) Low-molecular-weight heparins. N Engl J Med 337: 688 - 698
Hoek JA, Nurmohamed MT, Hamelynck KJ et al. (1992) Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid. Thromb Haemost 67: 28 - 32
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Japan
About this paper
Cite this paper
Goldhaber, S.Z. (1999). Overview of Pulmonary Embolism. In: Nakano, T., Goldhaber, S.Z. (eds) Pulmonary Embolism. Springer, Tokyo. https://doi.org/10.1007/978-4-431-66893-0_1
Download citation
DOI: https://doi.org/10.1007/978-4-431-66893-0_1
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-66895-4
Online ISBN: 978-4-431-66893-0
eBook Packages: Springer Book Archive